Publications by authors named "Alberto Lue"

Claim this Profile
B
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy.
Marta Fortuny, Leonardo G da Fonseca, Manon Allaire, Rocío Sánchez, Jean-Charles Nault, Alberto Lue

Liver Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving epidemiology of HCC in Spain.
Margarita Sala, Sonia Pascual, Maria Rosa Rota Roca, Ana María Matilla, Marta Campos

JHEP Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases.
Silvia Espina, Diego Casas-Deza, Vanesa Bernal-Monterde, María José Domper-Arnal, Sandra García-Mateo

Nutrients· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long COVID in Children: A Multidisciplinary Review.
Francesco Sansone, Giulia Michela Pellegrino, Antonio Caronni, Federica Bonazza, Elena Vegni

Diagnostics (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer.
Gonzalo Hijos-Mallada, Nuria Saura, Alberto Lué, Raúl Velamazan, Rocío Nieto

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with lesion detection in colonoscopy among different indications.
Carolina Mangas-Sanjuan, Agustin Seoane, Marco Antonio Alvarez-Gonzalez, Alberto Luè, Adolfo Suárez

United European Gastroenterol J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Donor and Surgical Factors Affect the Viability and Functionality of Human Hepatocytes Isolated From Liver Resections.
Estela Solanas, Nieves Sanchez-Fuentes, Alejandro Serrablo, Alberto Lue, Sara Lorente

Front Med (Lausanne)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients.
Gonzalo Hijos-Mallada, Raul Velamazán, Raúl Marti, Eduardo Chueca, Samantha Arechavaleta

Diagnostics (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of COVID-19 on liver cancer management (CERO-19).
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jean-Charles Nault, Gonzalo Sapisochin

JHEP Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort.
Gonzalo Hijos-Mallada, Alberto Lué, Raul Velamazan, Nuria Saura, Carlos Abril

Front Med (Lausanne)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Liver and Pancreas Diseases on Nutritional Status.
Pablo Cañamares-Orbis, Vanesa Bernal-Monterde, Olivia Sierra-Gabarda, Diego Casas-Deza, Guillermo Garcia-Rayado

Nutrients· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance.
Mercedes Navarro, Gonzalo Hijos, Carlos Sostres, Alberto Lué, Juan Jose Puente-Lanzarote

Front Med (Lausanne)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis.
Álvaro Díaz-González, Marco Sanduzzi-Zamparelli, Leonardo G da Fonseca, Giovan G Di Costanzo, Rogerio Alves, Alberto Lue

Liver Int· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in Colonoscopy Performance Measures According to Procedure Indication.
Carolina Mangas-Sanjuan, Enrique Santana, Joaquín Cubiella, Elena Rodríguez-Camacho, Agustín Seoane

Clin Gastroenterol Hepatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology.
Alberto Lué, Gonzalo Hijos, Carlos Sostres, Alba Perales, Mercedes Navarro

Therap Adv Gastroenterol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation.
Alberto Lué, Elena Martinez, Mercedes Navarro, Viviana Laredo, Sara Lorente

Transplantation· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young age and tobacco use are predictors of lower medication adherence in inflammatory bowel disease.
Ignacio Bruna-Barranco, Alberto Lué, Carla J Gargallo-Puyuelo, María T Arroyo, Erika Alfambra

Eur J Gastroenterol Hepatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft survival after liver transplantation: an approach to a new Spanish risk index.
Juan José Araiz Burdio, María Trinidad Serrano Aulló, Agustín García Gil, Ana Pascual Bielsa, Alberto Lue

Rev Esp Enferm Dig· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib.
Alberto Lué, Maria Trinidad Serrano, Francisco Javier Bustamante, Mercedes Iñarrairaegui, Juan Ignacio Arenas

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilars in inflammatory bowel disease.
Carla J Gargallo, Alberto Lué, Fernando Gomollón

Minerva Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Cyanocobalamin is Effective in the Treatment of Vitamin B12 Deficiency in Crohn's Disease.
Fernando Gomollón, Carla J Gargallo, Jose Fernando Muñoz, Raquel Vicente, Alberto Lue

Nutrients· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits.
Alberto Lué, Angel Lanas

World J Gastroenterol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical Treatment of Diverticular Disease: Antibiotics.
Alberto Lué, Viviana Laredo, Angel Lanas

J Clin Gastroenterol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib.
Manuel A de la Torre, Juan Buades-Mateu, Pedro A de la Rosa, Alberto Lué, Francisco J Bustamante

Liver Int· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How important is donor age in liver transplantation?
Alberto Lué, Estela Solanas, Pedro Baptista, Sara Lorente, Juan J Araiz

World J Gastroenterol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis